Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$437M |
| 2 |
Verizon
VZ
|
+$215M |
| 3 |
Comcast
CMCSA
|
+$137M |
| 4 |
Vodafone
VOD
|
+$137M |
| 5 |
Kinder Morgan
KMI
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$263M |
| 2 |
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
|
+$246M |
| 3 |
Walmart Inc
WMT
|
+$229M |
| 4 |
Pfizer
PFE
|
+$221M |
| 5 |
Costco
COST
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.93% |
| 2 | Consumer Discretionary | 13.29% |
| 3 | Healthcare | 11.79% |
| 4 | Industrials | 11% |
| 5 | Consumer Staples | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Evercore
EVR
$11.5B
| $8.26M | 0.02% |
149,540
-67,760
| -31% | -$3.88M |
|
|
ACOR
977
DELISTED
Acorda Therapeutics
ACOR
| $8.25M | 0.02% |
1,813
-274
| -13% | -$1.11M |
|
978
LendingTree
TREE
$444M
| $8.23M | 0.02% |
265,086
+80,886
| +44% | +$2.64M |
|
|
MITT
979
TPG Mortgage Investment Trust
MITT
$213M
| $8.23M | 0.02% |
156,613
+20,213
| +15% | +$1.04M |
|
|
ARR
980
Armour Residential REIT
ARR
$2.36B
| $8.2M | 0.02% |
49,784
+37,585
| +308% | +$6.3M |
|
981
Greenlight Captial
GLRE
$505M
| $8.2M | 0.02% |
250,105
+154,205
| +161% | +$4.98M |
|
982
CDW
CDW
$17.1B
| $8.19M | 0.02% |
298,526
+100,828
| +51% | +$2.49M |
|
|
PEI
983
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $8.18M | 0.02% |
30,204
+25,424
| +532% | +$7.08M |
|
984
Novartis
NVS
$290B
| $8.16M | 0.02% |
107,136
-628,641
| -85% | -$45.8M |
|
985
AB InBev
BUD
$156B
| $8.12M | 0.02% |
+77,100
| New | +$7.82M |
|
|
ATW
986
DELISTED
Atwood Oceanics
ATW
| $8.05M | 0.02% |
159,718
-612,182
| -79% | -$29.6M |
|
|
NSU
987
DELISTED
Nevsun Resources Ltd.
NSU
| $8.04M | 0.02% |
2,383,300
+18,900
| +0.8% | +$70.4K |
|
988
First Industrial Realty Trust
FR
$8.4B
| $8.02M | 0.02% |
415,187
+370,079
| +820% | +$6.69M |
|
|
EVRI
989
DELISTED
Everi Holdings
EVRI
| $8.02M | 0.02% |
1,168,845
+72,367
| +7% | +$616K |
|
990
Rithm Capital
RITM
$5.71B
| $8.01M | 0.02% |
618,905
+568,451
| +1,127% | +$7.33M |
|
991
Amkor Technology
AMKR
$13.8B
| $8M | 0.02% |
1,165,481
+270,881
| +30% | +$1.58M |
|
|
CUTR
992
DELISTED
Cutera, Inc.
CUTR
| $7.99M | 0.02% |
714,000
+93,800
| +15% | +$955K |
|
|
LTM
993
DELISTED
LIFE TIME FITNESS INC
LTM
| $7.96M | 0.02% |
165,600
-155,800
| -48% | -$7.11M |
|
|
STSA
994
DELISTED
STERLING FINL CORP (WA) COM NEW
STSA
| $7.96M | 0.02% |
238,943
-75,300
| -24% | -$2.44M |
|
995
VEON
VEON
$3.92B
| $7.96M | 0.02% |
35,262
+9,978
| +39% | +$2.56M |
|
996
Synaptics
SYNA
$4.3B
| $7.94M | 0.02% |
+132,229
| New | +$7.85M |
|
997
Helen of Troy
HELE
$696M
| $7.93M | 0.02% |
114,514
+59,114
| +107% | +$3.59M |
|
|
LDL
998
DELISTED
Lydall, Inc.
LDL
| $7.92M | 0.02% |
346,500
-6,400
| -2% | -$125K |
|
|
VASC
999
DELISTED
Vascular Solutions Inc
VASC
| $7.92M | 0.02% |
302,300
+31,200
| +12% | +$777K |
|
1000
MBIA
MBI
$254M
| $7.9M | 0.02% |
+564,838
| New | +$7.2M |
|
Similar funds
Jim Simons's Q1 2014 Portfolio in Review
As of Q1 2014, Jim Simons held 3,290 positions worth $41.7B, down 0.16% from $41.8B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q1 2014 filing shows 474 new, 1,340 increased, 961 reduced and 495 closed positions. Its largest new stake was Apple: 22,998,136 shares worth $441M. The largest sale was Johnson & Johnson, an estimated $263M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jim Simons's largest Q1 2014 buy was Apple: 22,998,136 shares worth $441M.
- Jim Simons added most to Verizon in Q1 2014, an estimated $215M increase.
- Jim Simons's biggest Q1 2014 reduction was Johnson & Johnson, cutting an estimated $263M.
- Jim Simons fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $246M.
- Jim Simons's ten largest holdings make up 13% of its $41.7B portfolio in Q1 2014.
- Jim Simons opened 474 new positions and closed 495 in Q1 2014.
- Jim Simons's portfolio value fell 0.16% quarter-over-quarter to $41.7B.
Based on Renaissance Technologies's 13F filing for Q1 2014, filed 14 May 2014.